BioSpace News Archive

Sonnet BioTherapeutics Holdings, Inc. announced that data from preclinical studies of the company’s proprietary Fully-Human Albumin Binding candidates, SON-1010, SON-1210, and SON-1410, will be presented in a poster session at the American Association for Cancer Research Annual Meeting 2022, April 8-13, in New Orleans, Louisiana.

Carisma Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced study findings accepted for presentation at The American Association for Cancer Research (AACR) Annual Meeting taking place in New Orleans, LA, Friday, April 8 – Wednesday, April 13.

Seagen Inc. (Nasdaq: SGEN) today announced data from intravesical instillation of enfortumab vedotin (EV) in a non-muscle invasive bladder cancer (NMIBC) preclinical model in addition to preclinical data from SGN-ALPV and SGN-B7H4V, two of its novel antibody-drug conjugates (ADCs) that utilize the company’s proprietary vedotin drug linker technology.

Cytovia Therapeutics, Inc., a biopharmaceutical company empowering natural killer (NK) cells to fight cancer through stem cell engineering and multispecific antibodies, announced today that the novel data it is presenting at the American Association of Cancer Research’s annual meeting in New Orleans on April 12th, 2022 is now available on both the AACR and Cytovia websites.

The global medical fiber optics market size is predicted to surpass around USD 2.6 billion by 2030 from valued at USD 920.9 million in 2020, growing at a CAGR of 6.02% from 2022 to 2030.

Modern medicine has evolved drastically over the years. From home remedies to targeted medicines, the healthcare sector has witnessed significant breakthroughs.

Abiomed, Inc . (NASDAQ: ABMD) announced that on Thursday, April 28, 2022, the Company will release financial results for the fourth quarter of the fiscal year 2022.

IsoPlexis Corporation (NASDAQ: ISO ), the Superhuman Cell Company, today announced that data generated using its Duomic™ platform demonstrates the ability to connect T Cell Receptor (TCR) diversity to the most functionally potent single cells.

Novocure (NASDAQ: NVCR) today announced 19 presentations on Tumor Treating Fields (TTFields) will be delivered at the American Association for Cancer Research (AACR) Annual Meeting 2022, to be held in New Orleans from April 8 to April 13, 2022.

Diffusion Pharmaceuticals Inc. today announced a postponement of its Special Meeting of Stockholders.